Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-27T10:28:33.881Z Has data issue: false hasContentIssue false
  • English
  • Français

Usage of clozapine and the new neuroleptics

A postal questionnaire survey among general psychiatrists

Published online by Cambridge University Press:  02 January 2018

M. F. Bristow
M. F. Bristow*
Affiliation:
Cheam Resource Centre, 671 London Road, North Cheam SM3 9DL
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and method

To explore clozapine and atypical antipsychotic usage in England and Wales, particularly availability, restrictions on use and shifting of prescribing to general practitioners. To examine the hypothesis that respondents in acute trusts would encounter more restrictions. Method used – postal questionnaire sent to general psychiatrists derived from the 1996 Medical Directory.

Results

There was an 80% response rate and over 90% of respondents used clozapine, with only 9% reporting any difficulty in obtaining it. Difficulty was not associated with any particular type of trust. Only about 4% of respondents suggested that general practitioners regularly took over the prescribing costs of the drug.

Clinical implications

Optimistic, with widespread usage and few difficulties in obtaining clozapine. General practitioner prescribing is still very low and needs to increase.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 23 , Issue 8: The Journal of Trends in Psychiatric Practice , August 1999 , pp. 478 - 480
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1999 The Royal College of Psychiatrists

References

Aitchison, K. J. & Kerwin, R. W. (1997) Cost effectiveness of clozapine. A UK clinic-based study. British Journal of Psychiatry, 171, 125 130.Google Scholar
Healy, D. (1993) Psychopharmacology and the ethics of resource allocation. British Journal of Psychiatry, 182, 23 28.Google Scholar
Launer, M. (1995) Clozapine in schizophrenia. Lancet, 345, 1435 1436.Google Scholar
Medical Directory (1996) The Medical Directory 1996. London: Cartermill International Ltd.Google Scholar
Meltzer, H. Y. & Cola, P. A. (1994) The pharmacoeconomics of clozapine. Journal of Clinical Psychiatry, 55 (suppl. B), 161 165.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.